These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 29080747)
1. TRIP6 promotes cell proliferation in hepatocellular carcinoma via suppression of FOXO3a. Zhao W; Dai Y; Dai T; Xie T; Su X; Li J; Zhou X; Meng K; Zhao X Biochem Biophys Res Commun; 2017 Dec; 494(3-4):594-601. PubMed ID: 29080747 [TBL] [Abstract][Full Text] [Related]
2. TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma. Wang F; Zhang B; Xu X; Zhu L; Zhu X Pathol Res Pract; 2020 Apr; 216(4):152850. PubMed ID: 32046874 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma. Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725 [TBL] [Abstract][Full Text] [Related]
4. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs. Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629 [TBL] [Abstract][Full Text] [Related]
5. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a. Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774 [TBL] [Abstract][Full Text] [Related]
6. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma. Wang Y; Dong L; Liu Y Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277 [No Abstract] [Full Text] [Related]
7. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells. Li F; Dong X; Lin P; Jiang J Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma. Li C; Liao J; Wu S; Fan J; Peng Z; Wang Z Biochem Biophys Res Commun; 2017 Dec; 494(3-4):511-517. PubMed ID: 29106957 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Forkhead Box O3a and Its Association With Aggressive Phenotypes and Poor Prognosis in Human Hepatocellular Carcinoma. Ahn H; Kim H; Abdul R; Kim Y; Sim J; Choi D; Paik SS; Shin SJ; Kim DH; Jang K Am J Clin Pathol; 2018 Jan; 149(2):117-127. PubMed ID: 29365018 [TBL] [Abstract][Full Text] [Related]
10. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma. Wang H; Li W; Jin X; Cui S; Zhao L Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841 [TBL] [Abstract][Full Text] [Related]
11. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1. Kan H; Huang Y; Li X; Liu D; Chen J; Shu M Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361 [TBL] [Abstract][Full Text] [Related]
12. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling. Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940 [TBL] [Abstract][Full Text] [Related]
13. The Zyxin-related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth. Grunewald TG; Willier S; Janik D; Unland R; Reiss C; Prazeres da Costa O; Buch T; Dirksen U; Richter GH; Neff F; Burdach S; Butt E Biol Cell; 2013 Nov; 105(11):535-47. PubMed ID: 24033704 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma. Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052 [TBL] [Abstract][Full Text] [Related]
15. Autocrine STIP1 signaling promotes tumor growth and is associated with disease outcome in hepatocellular carcinoma. Chen Z; Xu L; Su T; Ke Z; Peng Z; Zhang N; Peng S; Zhang Q; Liu G; Wei G; Guo Y; He M; Kuang M Biochem Biophys Res Commun; 2017 Nov; 493(1):365-372. PubMed ID: 28887036 [TBL] [Abstract][Full Text] [Related]
16. TRIP6 regulates p27 KIP1 to promote tumorigenesis. Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869 [TBL] [Abstract][Full Text] [Related]
17. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
18. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells. Yang LJ; Tang Q; Wu J; Chen Y; Zheng F; Dai Z; Hann SS J Exp Clin Cancer Res; 2016 Mar; 35():59. PubMed ID: 27036874 [TBL] [Abstract][Full Text] [Related]
19. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo. Fang F; Yang L; Tao Y; Qin W Cancer; 2012 Jan; 118(1):134-46. PubMed ID: 21713761 [TBL] [Abstract][Full Text] [Related]
20. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma. Yu M; Tang Z; Meng F; Tai M; Zhang J; Wang R; Liu C; Wu Q Tumour Biol; 2016 Jan; 37(1):1289-97. PubMed ID: 26289845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]